Revascular Bio
Pharmaceutical Manufacturing
Suita-shi Osaka, Jp
2 employees
- Employees
- 2
Revascular Bio Overview
- Headquarters
- Suita-shi Osaka, Jp
- Website
- www.revascularbio.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 2
- Founded
- 2022
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Revascular Bio
We have developed the world's first discovery of vascular-specific stem cells as cell therapy, providing groundbreaking solutions for the patients suffering from unresolved microvascular diseases. Our patented seed technology, vascular endothelial stem cells, is distributed in blood vessels throughout the body and is essential for the maintenance and regeneration of blood vessels in the body. We provide novel solutions for many microvascular diseases through two therapeutic concepts. The first is angiogenesis therapy, which can be applied to digital ulcers of systemic sclerosis, diabetic wounds, critical limb ischemia, vascular dementia, breast reconstruction, etc. The second, with angiocrine therapy, it is possible to completely cure hemophilia and lysosomal storage disorder through cell transplantation.
Revascular Bio Contact Details
- People in AeroLeads
- 1
Revascular Bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Kazuo Omori | CEO of Revascular Bio/ Md | Osaka, Japan |
View
|
Compare Similar Companies to Revascular Bio
Mirai Innovation Research Institute
Technical And Vocational Training
KIKO TECH CO.,LTD
Biotechnology
ATTP (The Alliance of Technology Transfer Professionals)
Non-Profit Organizations
Saisei Ventures
Venture Capital And Private Equity Principals
KOTAI Biotechnologies, Inc.
Biotechnology
Luxna Biotech Co., Ltd.
Biotechnology Research
Gut Feelings Psychosomatic Medicine
Mental Health Care
Nuanced Health
Biotechnology Research
NextVivo
Biotechnology Research
FET Open GLADIATOR
Research Services